GE HealthCare Launched CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
On August 24, 2023, GE HealthCare launched CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data relevant to disease progression from multiple data sources and driving evidence-based clinical decision support directed by up-to-date AFib guidelines.
More than 60% of deaths caused by cardiovascular diseases are avoidable and premature, making them the leading cause of death worldwide. AFib is the most prevalent arrhythmia diagnosed in clinical practice unde...